Company News Archives - Page 209 of 302

20AprApril 20, 2020

Orocobre (ASX:ORE) complete acquisition of Advantage Lithium

04 Apr 2020 - Orocobre (ASX:ORE) has acquired 100 per cent of the issued and outstanding shares of Advantage Lithium Corp.

20AprApril 20, 2020

Caltex Australia (ASX:CTX) report Alimentation Couche-Tard take-over will not go-ahead

20 Apr 2020 - Caltex Australia (ASX:CTX) and Alimentation Couche-Tard Inc. have decided to not proceed with the acquisition proposal due to the high level of economic uncertainty caused by the COVID-19 pandemic.

17AprApril 17, 2020

Coca-Cola Amatil (ASX:CCL) trading update

17 Apr 2020 - Coca-Cola Amatil (ASX:CCL) has released a trading update on the group’s performance for the first quarter of 2020.

17AprApril 17, 2020

Vista Group International (ASX:VGL) completes NZ$25 million placement

17 Apr 2020 - Vista Group International (ASX:VGL) has successfully completed both its NZ$25 million placement and the institutional entitlement offer component of its 1 for 4.37 pro-rata accelerated entitlement offer.

17AprApril 17, 2020

Bapcor (ASX:BAP) completes successful $180 million placement

17 Apr 2020 - Bapcor (ASX:BAP) has successfully completed its $180 million institutional placement. Under the placement the company will issue around 40.9 million new fully paid ordinary shares to institutional investors at a price of $4.40 per share.

17AprApril 17, 2020

Telstra (ASX:TLS) announces 500 euro million bond

17 Apr 2020 - Telstra (ASX:TLS) has announced a €500 million bond. The notes are expected to be issued on 23 April 2020 and will have a 10-year maturity.

16AprApril 16, 2020

Inghams Group (ASX:ING) Board appointed

16 Apr 2020 - Inghams Group (ASX:ING) has appointed Michael Ihlein to its Board.

16AprApril 16, 2020

Mayne Pharma (ASX:MYX) submits oral contraceptive FDA approval application

16 Apr 2020 - Mayne Pharma (ASX:MYX) has submitted a new drug application to the US Food and Drug Administration (FDA) its E4/DRSP oral contraceptive.